Supraventricular tachycardia AHA recommendations for Management of SVT in Pregnant Patients: Difference between revisions
Aysha Aslam (talk | contribs) |
Aysha Aslam (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Management of SVT in Pregnant Patients== | ==Management of SVT in Pregnant Patients== | ||
===Acute treatment of SVT in pregnant patient=== | |||
{|class="wikitable" style="width:80%" | {|class="wikitable" style="width:80%" | ||
|- | |- | ||
| Line 40: | Line 41: | ||
SVT when other therapies are ineffective or contraindicated <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C-LD]])'' <nowiki>"</nowiki> | SVT when other therapies are ineffective or contraindicated <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C-LD]])'' <nowiki>"</nowiki> | ||
|} | |||
===Management of ongoing SVT in Pregnant Patients=== | |||
{|class="wikitable" style="width:80%" | |||
|- | |||
| colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | |||
|- | |||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.'''The following drugs, alone or in combination, can be effective for ongoing management in pregnant | |||
patients with highly symptomatic SVT: | |||
a. Digoxin, b. Flecainide, c. Metoprolol, d. Propafenone, e. Propranolol, f. Sotalol, g. Verapamil<nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C-LD]])'' <nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" style="width:80%" | |||
|- | |||
| colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIb]] | |||
|- | |||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.'''Catheter ablation may be reasonable in pregnant patients with highly symptomatic, recurrent, drug-refractory SVT with efforts toward minimizing radiation exposure <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C-LD]])'' <nowiki>"</nowiki> | |||
|- | |||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.'''Oral amiodarone may be considered for ongoing management in pregnant patients when treatment of highly symptomatic, recurrent SVT is required and other therapies are ineffective or contraindicated <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C-LD]])'' <nowiki>"</nowiki> | |||
|} | |} | ||
Revision as of 19:16, 26 October 2016
|
Supraventricular tachycardia Microchapters |
|
Differentiating Among the Different Types of Supraventricular Tachycardia |
|---|
|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
|
Diagnosis |
|
Treatment |
|
2015 ACC/AHA Guideline Recommendations |
|
Case Studies |
|
Supraventricular tachycardia AHA recommendations for Management of SVT in Pregnant Patients On the Web |
|
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of SVT in Pregnant Patients |
|
FDA on Supraventricular tachycardia AHA recommendations for Management of SVT in Pregnant Patients |
|
CDC on Supraventricular tachycardia AHA recommendations for Management of SVT in Pregnant Patients |
|
Blogs on Supraventricular tachycardia AHA recommendations for Management of SVT in Pregnant Patients |
|
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Management of SVT in Pregnant Patients
Acute treatment of SVT in pregnant patient
| Class I |
| "1.Vagal maneuvers are recommended for acute treatment in pregnant patients with SVT "(Level of Evidence:C-LD ) " |
| "2.Adenosine is recommended for acute treatment in pregnant patients with SVT "(Level of Evidence:C-LD ) " |
| "3.Synchronized cardioversion is recommended for acute treatment in pregnant patients with hemodynamically unstable SVT when pharmacological therapy is ineffective or contraindicated "(Level of Evidence:C-LD ) " |
| Class IIa |
| "1.Intravenous metoprolol or propranolol is reasonable for acute treatment in pregnant patients with SVT when
adenosine is ineffective or contraindicated "(Level of Evidence:C-LD ) " |
| Class IIb |
| "1.Intravenous verapamil may be reasonable for acute treatment in pregnant patients with SVT when adenosine and
beta blockers are ineffective or contraindicated"(Level of Evidence:C-LD) " |
| "2.Intravenous procainamide may be reasonable for acute treatment in pregnant patients with SV "(Level of Evidence:C-LD) " |
| "3.Intravenous amiodarone may be considered for acute treatment in pregnant patients with potentially lifethreatening
SVT when other therapies are ineffective or contraindicated "(Level of Evidence:C-LD) " |
Management of ongoing SVT in Pregnant Patients
| Class IIa |
| "1.The following drugs, alone or in combination, can be effective for ongoing management in pregnant
patients with highly symptomatic SVT: a. Digoxin, b. Flecainide, c. Metoprolol, d. Propafenone, e. Propranolol, f. Sotalol, g. Verapamil"(Level of Evidence:C-LD) " |
| Class IIb |
| "1.Catheter ablation may be reasonable in pregnant patients with highly symptomatic, recurrent, drug-refractory SVT with efforts toward minimizing radiation exposure "(Level of Evidence:C-LD) " |
| "2.Oral amiodarone may be considered for ongoing management in pregnant patients when treatment of highly symptomatic, recurrent SVT is required and other therapies are ineffective or contraindicated "(Level of Evidence:C-LD) " |